BioCryst Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
BioCryst Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioCryst Pharmaceuticals Inc
Access all reports
BioCryst Pharmaceuticals Inc develops and commercializes oral medications for rare and serious diseases. The company focuses on small-molecule therapeutics, including treatments for hereditary angioedema and viral infections. Its research pipeline supports expansion into additional indications. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Key slides for BioCryst Pharmaceuticals Inc
Q2 2024
BioCryst Pharmaceuticals Inc
Q4 2024
BioCryst Pharmaceuticals Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
BCRX
Country
🇺🇸 United States